Rice Hall James & Associates LLC cut its position in Simulations Plus Inc. (NASDAQ:SLP) by 0.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 65,810 shares of the company’s stock after selling 512 shares during the period. Rice Hall James & Associates LLC’s holdings in Simulations Plus were worth $498,000 as of its most recent filing with the SEC.
Separately, Geode Capital Management LLC increased its stake in shares of Simulations Plus by 26.6% in the first quarter. Geode Capital Management LLC now owns 58,765 shares of the company’s stock valued at $518,000 after buying an additional 12,357 shares during the last quarter. Institutional investors and hedge funds own 25.30% of the company’s stock.
Shares of Simulations Plus Inc. (NASDAQ:SLP) traded up 4.04% during midday trading on Monday, hitting $8.75. The company had a trading volume of 49,258 shares. The firm has a market cap of $149.20 million, a price-to-earnings ratio of 32.41 and a beta of -0.26. Simulations Plus Inc. has a one year low of $6.74 and a one year high of $11.89. The company’s 50 day moving average is $8.65 and its 200 day moving average is $8.22.
Simulations Plus (NASDAQ:SLP) last issued its earnings results on Thursday, July 14th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.12 by $0.01. The company earned $6.01 million during the quarter. Simulations Plus had a return on equity of 22.89% and a net margin of 23.58%. Equities analysts forecast that Simulations Plus Inc. will post $0.28 earnings per share for the current fiscal year.
Separately, Zacks Investment Research upgraded Simulations Plus from a “sell” rating to a “hold” rating in a report on Wednesday, October 5th.
About Simulations Plus
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus Inc. (NASDAQ:SLP).
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.